S.2209, Research Credit Improvement Act.  Lobbied in favor of permanent research and development tax credits. Sprycel Reimbursement in Korea.  Lobbied to get Korean Government to adhere to its reimbursement procedures. H.R. 5629, Pathway for Biosimilars Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 1424, The Paul Wellstone Mental Health and Addiction Equity Act. Lobbied Members of Congress in support of mental health parity and against increased Medicaid rebates.
S. 2731/ H.R. 5501, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008. Lobbied Members of Congress in support of reauthorization of the Presidents Emergency Program for AIDS Relief.
S. 558, Mental Health Parity Act. Lobbied Members of Congress in support of mental health parity and against increased Medicaid rebates.
H.R. 1038/S. 623, Access to Life-Saving Medicine Act. Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons.
H.R. 1956, Patient Protection and Innovative Biologic Medicines Act. Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons.
H.R. 5629, Pathway for Biosimilars Act. Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons.
S. 1505, Affordable Biologics for Consumers Act. Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons.
H.R. 3610, Food and Drug Import Safety Act of 2007. Lobbied to ensure safety and access to prescription drugs.
S. 999, The STOP Stroke Act. Lobbied for passage of bill.
Labor, HHS Appropriations bill(No Bill Number Yet). Lobbied to ensure patient access to HIV drugs through the ADAP program. S. 2320, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007.Lobbied for passage of bill.
Medicare Part D Oversight (No Bill Number Yet). Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. Infant formula can liners (No bill).Lobbied to inform Members of Congress on the safety of materials used to line cans of infant formula. Pharmaceuticals in the environment. Lobbied to educate Members of Congress on the issue of pharmaceuticals in the environment. S.B. 2302 and HR 2419, Food and Energy Security Act of 2007 Farm Nutrition and Bioenergy Act of 2007. Lobbied against the proposed non deductibility increase on companies involved with settlement agreements with government agencies. H.R. 1908 and S. 1145, Patent Reform Act of 2007. Lobbied Members of Congress to improve provisions related to inequitable conduct and damages.
TAX - Taxation/Internal Revenue Code TRD - Trade (domestic/foreign) HCR - Health Issues MMM - Medicare/Medicaid CSP - Consumer Issues/Safety/Products CAW - Clean Air and Water (quality) AGR - Agriculture CPT - Copyright/Patent/Trademark
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR)
BRISTOL-MYERS SQUIBB COMPANY
801 Pennsylvania Ave, NW, Suite 745, WASHINGTON, DC, 20004, US
JOHN RYAN DAVID E WARR MICHAEL CAROZZA LANE PENRY CHRISTOPHER PERNIE RICHARD THOMPSON MICHAEL CAROZZA LANE PENRY CHRISTOPHER PERNIE MICHAEL CAROZZA MICHAEL CAROZZA LANE PENRY CHRISTOPHER PERNIE JOHN RYAN MICHAEL CAROZZA CHRISTOPHER PERNIE